Viewing nowCombinationGlyan Duo Tablets 5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin Amorphous 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.

MFDS item code 202201389 · Approved 2022.04.04 · Insurance code 643705640
Improvement of glycemic control in adults with type 2 diabetes
This medication is used to help adult patients with type 2 diabetes manage their blood sugar levels alongside diet and exercise therapy. It is particularly effective for patients whose blood sugar is not sufficiently controlled, and it can be used safely under a healthcare professional's guidance in cases of cardiovascular disease. This medication aids in diabetes management by improving blood sugar levels.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication lowers blood sugar; however, it should not be used by patients with significantly impaired kidney function, severe infections, heart problems, or liver dysfunction. During treatment, there is a risk of a rare but serious side effect called lactic acidosis, so if any unusual symptoms occur, consult a doctor immediately. Additionally, when using this medication in conjunction with insulin or other antihyperglycemic agents, the risk of hypoglycemia exists, so caution is required, and dosages of the antihyperglycemic agents may need adjustment if deemed necessary. If undergoing tests that use iodinated contrast agents, the use of this medication should be temporarily suspended before and after the procedure, and resumption should only occur after confirming normal kidney function. Women who are pregnant or breastfeeding should avoid taking this medication, and elderly patients or those with weak kidney function should undergo regular kidney function tests. This medication can increase urination, which may lead to dehydration or low blood pressure; therefore, patients who have dehydration symptoms or low blood pressure should be particularly cautious. During treatment, urinary or genital infections may occur, so any signs of infection require immediate medical attention, and vitamin B12 levels may decrease, so long-term users should have blood tests to monitor this. It is advisable to avoid alcohol consumption during treatment, and in case of acute illness or surgery while taking this medication, consult a doctor to consider temporarily halting medication use. Finally, this medication's safety and efficacy have not been established in children, so it is not recommended for patients under 18 years of age.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
Orange-yellow oval film-coated tablet with a double convex shape
30 tablets/box [(6 tablets/PTP x 5)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin Amorphous 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Empagliflozin Amorphous 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationEmpagliflozin Amorphous 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Empagliflozin Amorphous 25mg
Tablet · Prescription medication · Combination
Aprogen Pharmaceuticals Co., Ltd.
CombinationEmpagliflozin Amorphous 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Empagliflozin Amorphous 10mg
Tablet · Prescription medication · Combination
Aprogen Biosystems, Co., Ltd.
CombinationEmpagliflozin Amorphous 10mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationEmpagliflozin Amorphous 25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.